- No file added yet -

Supplementary Video SV1 from Toll-like Receptor Signaling–deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing

media

posted on 2023-04-04, 02:22 authored by Alvaro Morales-Molina, Miguel Ángel Rodriguez-Milla, Stefano Gambera, Teresa Cejalvo, Belén de Andrés, María-Luisa Gaspar, Javier García-Castro

OAd-MSC WT

Funding

MEC | Instituto de Salud Carlos III (ISCIII)

Consejería de Educación, Juventud y Deporte, Comunidad de Madrid (Ministry of Education, Youth and Sports, Government of Madrid)

Fundacion Oncohematologia Infantil

Asociación Pablo Ugarte (APU)

Afanion

History

ARTICLE ABSTRACT

Cells carrying drugs, virus, or other antitumor agents are commonly used for the treatment of cancer. This research shows that silent cells are excellent carriers for immunotherapies, improving tumor homing and enhancing the antitumor effect.

Usage metrics

Keywords

Immunotherapy Combination immunotherapy Cellular immunotherapy Biological Agents & Therapies Cell-based therapeutics Stem cell therapies Immunology Tumor immunology animal models Stem Cell Biology Mesenchymal stem cells

Licence

CC BY

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM